Sanofi EBIT 2010-2024 | SNY

Sanofi EBIT for the quarter ending December 31, 2024 was $1.054B, a 23.42% decline year-over-year.

  • Sanofi 2024 EBIT was 8.22B, a 14.32% decline from 2023.
  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.
  • Sanofi 2022 EBIT was 10.72B, a 8.88% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Sanofi EBIT 2010-2024 | SNY

  • Sanofi 2024 EBIT was 8.22B, a 14.32% decline from 2023.
  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.
  • Sanofi 2022 EBIT was 10.72B, a 8.88% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B